| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 259.47 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Objetivos: Avaliação da adesão à terapêutica em doentes recém-diagnosticados com Diabetes Mellitus tipo 2 e Hipertensão Arterial, nos Cuidados de Saúde Primários na Região Lisboa Vale Tejo. Metodologia: Estudo observacional de coorte retrospetivo. População composta pelos doentes recém-diagnosticados com Diabetes Mellitus tipo 2 e Hipertensão Arterial, em início de tratamento. Os dados foram extraídos do Sistema de Informação da Administração Regional de Saúde de Lisboa Vale Tejo. A adesão à terapêutica foi avaliada nas suas três componentes: se os doentes iniciaram a terapêutica prescrita (iniciação); através do Medication Possession Ratio (MPR) durante o período de seguimento (implementação) e a descontinuação da medicação, que marca o fim do tratamento (descontinuação). Resultados: A taxa de iniciação foi de 84.2% nos doentes com ambas as doenças (98% para a terapêutica antidiabética oral e 84.6% para a terapêutica anti-hipertensiva). A taxa de implementação (MPR) para ambas as doenças foi de, apenas 3.4% (4.2% foram considerados aderentes com a terapêutica antidiabética oral e 8.5% para a terapêutica anti-hipertensiva). A taxa de descontinuação foi de 3.4% (5.5% para a terapêutica antidiabética oral e 13.2% para terapêutica anti-hipertensiva). A maioria dos doentes iniciam a toma da medicação após a prescrição, mas poucos têm uma implementação suficiente para que a adesão seja considerada boa. Poucos doentes descontinuaram a medicação. Conclusão: Os doentes tiveram uma maior taxa de implementação à terapêutica anti-hipertensiva, mas, por outro lado, foram mais persistentes à terapêutica antidiabética oral. O padrão da adesão à terapêutica parece ser influenciado pelo doente e pela própria doença.
ABSTRACT - Aims: Assessment of medication adherence in newly diagnosed and treated patients with Type 2 Diabetes Mellitus and Arterial Hypertension, in the Primary Health Care Units of Lisbon and Tagus Valley. Methods: This is an observational and retrospective cohort study. The population is composed of newly diagnosed patients with Type 2 Diabetes Mellitus and Arterial Hypertension, at the beginning of treatment. Data was extracted from the Lisbon and Tagus Valley Regional Health Administration Information System. Medication adherence was assessed in three periods: patients started therapy or not after the professional's prescription (initiation); medication possession rate during the follow-up period (MPR) (implementation) and medication discontinuation, marking the end of therapy (discontinuation). Results: An initiation rate of 84.2% was obtained in patients with both diseases (98% for oral antidiabetic therapy and 84.6% for antihypertensive therapy). The implementation rates (MPR) for both diseases was only 3.4% (4.2% were considered adherent to oral antidiabetic therapy and 8.5% to antihypertensive therapy). The discontinuation rate was 3.4% (5.5% for oral antidiabetic therapy and 13.2% for antihypertensive therapy). Most patients initiate taking drugs after prescription but very few patients have an MPR enough to consider them having good adherence. Moreover, few patients discontinue the medication. Conclusions: Patients had a higher implementation rate to antihypertensive therapy but, on the other hand, were more persistent to oral antidiabetic therapy. Through this new assessment, the medication adherence pattern seems to be influenced by the patient and by the disease itself.
ABSTRACT - Aims: Assessment of medication adherence in newly diagnosed and treated patients with Type 2 Diabetes Mellitus and Arterial Hypertension, in the Primary Health Care Units of Lisbon and Tagus Valley. Methods: This is an observational and retrospective cohort study. The population is composed of newly diagnosed patients with Type 2 Diabetes Mellitus and Arterial Hypertension, at the beginning of treatment. Data was extracted from the Lisbon and Tagus Valley Regional Health Administration Information System. Medication adherence was assessed in three periods: patients started therapy or not after the professional's prescription (initiation); medication possession rate during the follow-up period (MPR) (implementation) and medication discontinuation, marking the end of therapy (discontinuation). Results: An initiation rate of 84.2% was obtained in patients with both diseases (98% for oral antidiabetic therapy and 84.6% for antihypertensive therapy). The implementation rates (MPR) for both diseases was only 3.4% (4.2% were considered adherent to oral antidiabetic therapy and 8.5% to antihypertensive therapy). The discontinuation rate was 3.4% (5.5% for oral antidiabetic therapy and 13.2% for antihypertensive therapy). Most patients initiate taking drugs after prescription but very few patients have an MPR enough to consider them having good adherence. Moreover, few patients discontinue the medication. Conclusions: Patients had a higher implementation rate to antihypertensive therapy but, on the other hand, were more persistent to oral antidiabetic therapy. Through this new assessment, the medication adherence pattern seems to be influenced by the patient and by the disease itself.
Description
Keywords
Farmacologia Hipertensão arterial Doença crónica Adesão à terapêutica Diabetes mellitus tipo 2 Pharmacology Hypertension Chronic disease Medication adherence Type 2 diabetes mellitus
Citation
Rosu A, Coelho A, Camacho P. Avaliação da adesão à terapêutica em doentes com diabetes tipo 2 e hipertensão arterial: adesão à medicação nas doenças crónicas. RevSALUS. 2024;6(1).
Publisher
RACS